Aliveplus Pharmacy

 

AliveplusPharmacy

 

 

(07) 849 3805


McAfee SECURE sites help keep you safe from identity theft, credit card fraud, spyware, spam, viruses and online scams

 


 

 

 

Aliveplus Newsletter

Don't miss out - sign up here
for exclusive special offers:
Subscribe

Optifast VLCD Vanilla Milkshake Sachets

Our International Customers, please visit: AlivePlusPharmacy AlivePlusPharmacy AlivePlusPharmacy AlivePlusPharmacy
Optifast VLCD Vanilla Milkshake Sachets
Product Use : Optifast VLCD Vanilla Milkshake Sachets provide restricted calories to assist weight loss.
Classification : General Health Product
Manufacturer Name : Nestle Healthcare Nutrition
1 packet of Optifast VLCD Vanilla Milkshake Sachets 40g 21 sachetsNZD $105.00
2 packets of Optifast VLCD Vanilla Milkshake Sachets 40g 42 sachetsNZD $206.80
3 packets of Optifast VLCD Vanilla Milkshake Sachets 40g 63 sachetsNZD $307.20
5 packets of Optifast VLCD Vanilla Milkshake Sachets 40g 105 sachetsNZD $506.50
Information - Optifast VLCD Vanilla Milkshake Sachets

Optifast VLCD Vanilla Milkshake Sachets help reduce the weight, therefore reducing the burden on your body.
It is now recognised that obesity is a complex, serious and chronic problem. The association between being overweight or obese and suffering from ill health is well documented.
Diseases and conditions such as:
Coronary heart disease
Heart failure
Stroke
Gallstones
Type 2 Diabetes
Osteoarthritis
Sleep Apnoea
Reproductive problems
High blood pressure
High blood cholesterol
are all likely in overweight or obese individuals.
A measure called the Body Mass Index (BMI) is commonly used by medical professionals to indicate if a person is obese or overweight. BMI is calculated by weight (kg) divided by height in metres squared.
A BMI of between 20 and 24.9 indicates a healthy weight range. A BMI of between 25 and 29.9 indicates a person is in the overweight range, while 30 and above indicates obesity.
Health may also be influenced by the location of the excess fat on the body. Excess abdominal fat is more likely to be associated with an increased risk of disease. Waist circumference is a useful measure of this.
The World Health Organisation (WHO) reports that a waist measurement greater than 94cm in men and 80cm in women indicates an increased health risk.
You have been recommended Optifast VLCD because you and a medical professional have decided to take charge of your weight and your health.
Optifast VLCD uses an established medical technique - a very low calorie diet (VLCD) - for rapid weight reduction. Reducing your calorie intake to below 800 Kcal (3344kj) per day means your body draws its energy from your own fats stores. Quite literally, you live off your own fat.
Optifast VLCD contains carbohydrates, essential fatty acids and high quality protein which helps to preserve lean body mass (muscle) while you lose your fat stores. It has been designed to be the sole source of nourishment and therefore contains the recommended dietary intake (RDI) of vitamins, minerals and trace elements.
Optifast VLCD is designed to totally replace your normal food intake
Three sachets of Dessert or Milkshake each mixed with 200ml water, every day for 12 weeks provide the essential nutrients required by the body as you lose weight.
A medical professional may also encourage you to have a maximum of two cups of low starch vegetables with your Optifast VLCD program each day.

Use

Intensive Phase:

Breakfast:

1 sachet of Optifast VLCD Dessert or Milkshake or
1 sachet of Optifast VLCD Soup

Lunch:
1 sachet of Optifast VLCD Dessert or Milkshake or
1 sachet of Optifast VLCD Soup

Dinner:
1 sachet of Optifast VLCD Dessert or Milkshake or
2 sachet of Optifast VLCD Soup

  • Mix each sachet with 200ml water and shake vigorously.
  • Do not use boiling water
  • If desired, more water may be added
  • Ingredients

    ingredients

    Important Notes

    Must be used under supervision of a health professional

    Rationale

  • The use of modified fasting is well established as a safe and effective method of rapid weight loss provided that medical supervision is maintained. Weight loss rates are comparable to those achieved by total fasting, but the disadvantages of severe ketosis and loss of lean body mass are minimised.
  • Adequate nutritional status is also maintained. Individuals have undertaken modified fasting regimes for many months but are advised to seek the advice of a doctor or healthcare professional to review progress.
  • Progress should be reviewed at least twice monthly if the duration of modified fasting exceeds one month.

    Indications
  • Total food replacement for the obese
  • Optifast VLCD is intended for use as part of the management of the moderately to severely overweight, even where there is associated secondary pathology e.g. non-insulin-dependent diabetes, hypertension, osteoarthritis, hypothyroidism corrected by replacement therapy, gynaecological disorders, hyperlipidaemia or where obesity is an impediment to surgery.

    Contraindications
  • Acute or cerebrovascular or cardiovascular disease, renal disease, hepatic disease, juvenile onset diabetes, porphyria or overt psychosis
  • Use in pregnancy is contraindicated
  • Use in lactation is contraindicated
  • Use in children is contraindicated

    Precautions
  • Individuals with recent myocardial infarction should be referred to a cardiologist to determine suitability for modified fasting.
  • Individuals should be screened for gall bladder disorders prior to commencement of modified fasting using Optifast VLCD
  • Individuals receiving medication for diabetes, hypertension, hyperlipidaemia or those on Lithium therapy may require a reduction in dose or withdrawal of treatment whilst undergoing modified fasting.
  • Such individuals should be monitored carefully in the first weeks of an Optifast VLCD program.
  • Individuals wiht a history of hepatic or renal disease should also be monitored carefully.
  • Individuals on lithium therapy require more frequent monitoring of blood lithium levels.
  • Alcohol should not be consumed when using Optifast VLCD

    Monitoring
  • At the commencement of the program, individuals should be checked for normal renal and hepatic function and thereafter regular checks for weight, blood pressure and urinalysis.

    Adverse Reactions
    Initial transient effects have been observed:
  • Sensitivity to cold
  • Dry skin
  • Temporary rash
  • Postural hypotension
  • Fatigue
  • Diarrhoea
  • Constipation
  • Muscle Cramps
  • Halitosis
  • Irritability
  • Menstrual Disturbances
    These are generally insufficient in magnitude or duration to warrant cessation of the program. In some rare cases, numbness and the appearance of previously unsuspected gallstones have been reported.

  • Rapid weight loss occasionally leads to higher serum uric acid levels and might precipitate and acute attack of gout in a predisposed individual. This may be ameliorated by ensuring adequate fluid intake, but in severe cases therapy such as allopurinol may be indicated.
  • Although Optifast VLCD contains adequate electrolytes for the needs of most individuals, some individuals may become hyponatraemic, or hypokalaemic, especially if they are receiving diuretic therapy. In such circumstances, electrolyte supplements may be required.

    Overdosage
  • Symptoms of overdosage would become apparent after prolonged ingestion of at least 22 sachets per day. Such symptoms would be due to an intake of over 25000 IU per day of Vitamin A, or over 600 micrograms of Selenium.
  • A yellow colouration of the skin may result due to the excessive intakes of the carotenes derived from the Vitamin A, but disappear when the carotenoid intake is reduced.
  • Signs of Selenium toxicity may include loss of hair and nails.
  • Potential toxicity may also result when persistent ingestion of large amounts of Vitamin D (cholecalciferol) exceed the recommended allowance by several-fold, and may result in hypercalcaemia and consequent calcification of soft tissues.

    More Information

    1. Intensive Phase
    During this initial phase, Optifast replaces ALL meals and must be taken in combination with 2 cups of low-starch, green vegetables and 2 litres of water per day.

    2. Transition Phase
    In this phase, Optifast replaces just TWO meals a day. One low-calorie meal (approximately 500 Calories) is introduced, in combination with 2 cups of low-starch, vegetables and 2 litres of water per day. One serving of fruit can also be included (see list of Allowed Foods).

    3. Maintenance Phase
    Once this phase is reached, Optifast replaces just ONE meal a day - in combination with 2 low calorie meals, 2 cups of low-starch vegetables and 2 litres of water per day.

    4. Stabilisation Phase
    Once weight loss goals have been achieved, you should be at a stage where you no longer require Optifast and you are eating healthy, low calorie meals. However, it is vital to maintain weight loss by ensuring calorie intake is restricted to less than about 1500 calories per day. Your health professional may advise you to use Optifast intermittently if you go above your healthy goal weight.

  •  



    © 2019   AlivePlusPharmacy   Sitemap and Policies